Adial Pharmaceuticals SG&A Expense (TTM) Analysis

Adial Pharmaceuticals Inc (ADIL)

1.15 +0.03 (+2.68%) USD | NASDAQ | Jun 28, 16:00

1.13 -0.02 (-1.74%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	5.108M
December 31, 2023	5.621M
September 30, 2023	6.167M
June 30, 2023	6.875M
March 31, 2023	8.391M
December 31, 2022	8.951M
September 30, 2022	8.984M
June 30, 2022	9.498M
March 31, 2022	9.019M
December 31, 2021	9.345M
September 30, 2021	8.652M
June 30, 2021	7.772M
March 31, 2021	6.618M
December 31, 2020	5.070M
September 30, 2020	4.550M

Date	Value
June 30, 2020	3.940M
March 31, 2020	3.958M
December 31, 2019	4.279M
September 30, 2019	4.435M
June 30, 2019	7.181M
March 31, 2019	7.897M
December 31, 2018	6.619M
September 30, 2018	5.846M
June 30, 2018	2.453M
March 31, 2018	0.9721M
December 31, 2017	0.8132M
September 30, 2017	0.6031M
June 30, 2017	0.4293M
March 31, 2017	0.3032M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

3.940M

Minimum

Jun 2020

9.498M

Maximum

Jun 2022

6.696M

Average

6.618M

Median

Mar 2021

SG&A Expense (TTM) Benchmarks